Peter O'Blenis

Peter O’Blenis is a co-founder of Evidence Partners and has assembled a collection of best practices and methodologies for using web-based software to streamline clinical research. He believes that well written web-enabled software can solve real-world problems and has presented globally on the topic.

Recent Posts

AI and Systematic Reviews: What's Real and What's Not

By Peter O'Blenis

Picture it: you’re embarking on a new systematic review. The research question is timely and important, and you’re excited to see what the evidence reveals.

However, your heart sinks at the thought of the thousands of papers that you and your team are likely to sift through over the weeks and...

What You Need to Know About the New EU Medical Device Regulations

By Peter O'Blenis

In April 2017, the European Parliament and Council adopted two new Medical Device Regulations (MDRs). Regulation 2017/745 sets quality and safety standards for devices other than in vitro diagnostics, which are now covered by MDR 2017/746 (commonly referred to as IVDR).

Comparing Systematic Review Tools: Beware the Feature Matrix

By Peter O'Blenis

Whether you’re choosing your next car or replacing your worn out sneakers, it's generally a good idea to do your research before you pull out your wallet.

The same applies when looking for software to help with your systematic review process. The tools available in this space vary greatly and it...

5 Best Practices for Optimizing Your Systematic Reviews

By Peter O'Blenis

Systematic reviews are viewed as the gold standard for evidence-based research. Used in a wide variety of healthcare fields including health economics outcomes research (HEOR), regulatory compliance, guidelines development, and evidence-based medicine, they are also gaining traction as a policy...

No Second Screener? There's A Robot For That

By Peter O'Blenis

Dual screening is a best practice for conducting systematic reviews, but there’s often not enough time or resources to have two people screen each reference. Good news: DistillerSR’s new automated screening tool, DistillerAI, can be used as the second screener. That’s right - you now have a...

How To Train Your Robot: Best Practices For Automated Screening

By Peter O'Blenis

DistillerAI made its global debut on Feb 11, 2018 in the latest release of the DistillerSR systematic review software platform. Since then, researchers around the world have been testing it and applying it to their literature reviews. In the process, they’ve discovered a few best practices for...

Rise Of The Robots: 3 Ways To Leverage Artificial Intelligence In Systematic Reviews Today

By Peter O'Blenis

The buzz about artificial intelligence (AI) just keeps getting louder. For the evidence-based research set, the potential of computer-based tools to automate screening and data extraction in systematic reviews has researchers excited about the possibilities - and maybe a little bit fearful of...

3 Reasons To Use DistillerSR Systematic Review Software For Data Extraction

By Peter O'Blenis

Many groups choose to do the data extraction phase of their systematic review in Distiller systematic review software for the same reasons they do screening in DistillerSR:

Vote Or Classify: Which Is Faster For Title And Abstract Screening?

By Peter O'Blenis

Two vital tenets of the systematic review process are transparency and reproducibility.  I have long argued that both should apply at every stage of the review process, including title and abstract screening.

There are two schools of thought on title and abstract screening when it comes to the...

Putting A Stop To Systematic Review Déjà Vu

By Peter O'Blenis

Systematic reviewers are prone to experiencing “déjà vu”, that indescribable gut feeling that you’ve done the exact same thing (or screened the same abstract) at some point in the past. Particularly if you specialize in a certain research topic, you may encounter the same references turning up...